DCIS: Clinical Trials

3 trials for DCIS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow DCIS: new trials by email Literature Review of DCIS trials Research Report on DCIS

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT 0.075 mg/kg - Breast Cancer, DCIS
Phase 1 / Phase 2CompletedIntegro Theranostics222023-07-142026-05-20
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Chloroquine Standard Dose (500mg/week), Chloroquine Low Dose (250mg/week), Breast Biopsy - Carcinoma, Intraductal, Noninfiltrating, DCIS
Phase 1 / Phase 2CompletedInova Health Care Services122009-12-012021-06-29
DC Vaccine for Patients With Ductal Carcinoma In Situ
HER-2 Pulsed Dendritic cell Vaccine - Breast Cancer, DCIS
Phase 1 / Phase 2CompletedAbramson Cancer Center at Penn Medicine582009-07-012020-04-10

Narrower conditions

Breast Neoplasms (3)  ·  Carcinoma, Intraductal, Noninfiltrating (3)  ·  Carcinoma, Ductal, Breast (1)

Broader conditions

Adenocarcinoma (3)  ·  Breast Carcinoma In Situ (3)  ·  Breast Diseases (3)  ·  Carcinoma (3)  ·  Carcinoma in Situ (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Ductal, Lobular, and Medullary (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Carcinoma, Ductal (1)

Interventions

Biopsy (1)  ·  Chloroquine (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Inova Health Care Services (1)  ·  Integro Theranostics (1)

Countries

United States (3)

Top investigators

Brian J Czerniecki, M.D., Ph.D. (1)  ·  Dan Thompson (1)  ·  Kirsten H Edmiston, MD, FACS (1)  ·  Priscilla McAuliffe, MD, PhD (1)

Results publications

PMID 20562526